Shaping Tomorrow’s Innovators
Shaping Tomorrow’s Innovators
CBM Partners is a boutique capital introduction firm based in New York City. Since 2014, we've helped early and mid-stage companies from diverse industries raise capital and make an impact.
CBM Partners is a boutique capital introduction firm based in New York City. Since 2014, we've helped early and mid-stage companies from diverse industries raise capital and make an impact.
Industry And Geography Focus
Healthcare/Biotech
Technology
Business Services (B2B/B2C)
North America
EMEA
Industry And Geography Focus
Healthcare/Biotech
Technology
Business Services (B2B/B2C)
North America
EMEA
Current Deals
Current Deals
Current Deals
❤️
CardioMech
CardioMech
$8M series A round (Medical Device/ Mitral Valve Repair)
$8M series A round
🌊
Poseydon
Poseydon
$4M Post Seed round (acute ischemic stroke)
$8M series A round
🧠
🧠
EpicNeuro
EpicNeuro
$4M Series A Round (Simple minimally invasive brain stimulation and cortical EEG for stroke)
$4M Series A Round
🚶🏿♂️
🚶🏿♂️
ReGelTec
ReGelTec
$4M seed round (Medical Device spinal implants)
$4M seed round
🏡
🏡
TPN Health
TPN Health
$3.4M Post Seed Round (B2B Behavioral Health)
$3.4M Post Seed Round
🦁
🦁
Lionheart Health
Lionheart Health
$3M Seed Round (Wellness/Longevity Technology)
$3M Seed Round
🖨️
MedSure Systems
MedSure Systems
$6.5M Post Seed Round (Medical Device/ Medication Management)
$6.5M Post Seed Round
🐟
🐟
APP (A Perfect Protein)
APP (A Perfect Protein)
$3M seed round (sustainable fish protein manufacturing)
$3M seed round
🏊🏿♀️
🏊🏿♀️
Swimply
Swimply
$10M series A round (Online Marketplace for private pool rentals)
$10M series A round
❤️🔋
🔋
Pacertool
Pacertool
$6.5 M Seed Round (Pacemaker Approach for Heart Failure Patients)
$6.5 M Seed Round
🚀
🚀
ARCA
ARCA
$10M in Series A funding (Crypto Hedgefund)
$10M in Series A funding
🌸
🌸
HekaBio
HekaBio
$10 M Series A Round (Medical Device Platform:Japan)
$10M Series A Round
❤️
Heart Repair Technologies (HRT Medical)
HRT Medical
$5M in Series B funding (Mitral Valve Innovation)
$5M in Series B funding
🍼
🍼
Momi Baby
Momi Baby
$4M Seed Round (Breast Pump/ Baby Bottles)
$4M Seed Round
🦠
🦠
MycoBiotix
MycoBiotix
$3M Seed Round (Microbiome)
$3M Seed Round
🛡️
🛡️
Luwi
Luwi
$1.5M Pre Seed Round (Female Condom)
$1.5M Pre Seed Round
Past Deals
Past Deals
Testimonials:
Tim Blair, CEO of ICHOR Vascular Inc.
Tim Blair, CEO of ICHOR Vascular Inc.
@ICHOR
@ICHOR
"Fundraising is the number one priority for early-stage innovators, CEOs, and entrepreneurs. Most innovations fail because of lack of funding which is why getting to more of the right investors with the right message at the right time is critical. CBM Partners has key tools and resources to help CEOs get to the masses helping young companies access key funding sources otherwise invisible to most early-stage technologies. A unique partnership young companies and new CEOs should consider."
"Fundraising is the number one priority for early-stage innovators, CEOs, and entrepreneurs. Most innovations fail because of lack of funding which is why getting to more of the right investors with the right message at the right time is critical. CBM Partners has key tools and resources to help CEOs get to the masses helping young companies access key funding sources otherwise invisible to most early-stage technologies. A unique partnership young companies and new CEOs should consider."
Rick Nehm, CEO of CardioMech AS
Rick Nehm, CEO of CardioMech AS
@CardioMech
@CardioMech
"I was always impressed with Craig at CBM Partners in the way I was approached as a prospective investor for his clients, so I hired him. With little up front effort, he was able to connect me with excellent prospects in short order. I was impressed with how easy he was to work with, his ability to connect with investors in his network, and I found his approach to be highly collaborative with both me and my team. I encourage others to consider working with Craig and CBM!"
"I was always impressed with Craig at CBM Partners in the way I was approached as a prospective investor for his clients, so I hired him. With little up front effort, he was able to connect me with excellent prospects in short order. I was impressed with how easy he was to work with, his ability to connect with investors in his network, and I found his approach to be highly collaborative with both me and my team. I encourage others to consider working with Craig and CBM!"
Trevor Calhoun, CEO of TPN Health
Trevor Calhoun, CEO of TPN Health
@TPN
@TPN
"Craig approached us with a rather distant connection, and we decided to take a chance on him to assist us in securing our Angel round and eventually series A round. Considering our company is a platform and not a product, the fundraising process was quite intricate. Throughout it all, Craig remained steadfast and readily accessible. Perhaps the most crucial aspect is that he managed to connect us with a staggering 160 investors, leaving no stone unturned until the task was accomplished. Undoubtedly, anyone would be immensely appreciative to have Craig as their ally in this endeavor."
"Craig approached us with a rather distant connection, and we decided to take a chance on him to assist us in securing our Angel round and eventually series A round. Considering our company is a platform and not a product, the fundraising process was quite intricate. Throughout it all, Craig remained steadfast and readily accessible. Perhaps the most crucial aspect is that he managed to connect us with a staggering 160 investors, leaving no stone unturned until the task was accomplished. Undoubtedly, anyone would be immensely appreciative to have Craig as their ally in this endeavor."
Justin Monger, CEO of MedSure Systems LLC
Justin Monger, CEO of MedSure Systems LLC
@MedSure
@MedSure
"We worked directly with Craig McKeon for the second half of 2022. During that time we arranged for some 140+ pitches to institutional investors. Craig works very hard and is easy to work with, he has a great rolodex of institutional investors. He is able to reach a significant number of potential strategic partners (non-investors) as well. Craig created a collaborative environment that allowed us to change up our approach to be even more effective. "
"We worked directly with Craig McKeon for the second half of 2022. During that time we arranged for some 140+ pitches to institutional investors. Craig works very hard and is easy to work with, he has a great rolodex of institutional investors. He is able to reach a significant number of potential strategic partners (non-investors) as well. Craig created a collaborative environment that allowed us to change up our approach to be even more effective. "